K-111
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
This article is part of Ahmed M. Khalid's PhD thesis, which is available in Munin: http://hdl.handle.net/10037/1802
Kozva Co Ltd, under license from Roche Holding AG, is developing K-111, an orally available peroxisome proliferator-activated…
Introduction: Prevalence of the metabolic syndrome has increased dramatically in recent years. Optimal patient care demands a…
This study was undertaken to investigate the hypocholesterolemic activity ofBifidobacteria (B. breve K-110,B. breve K-111, andB…
Panax ginseng is widely used as a Chinese medicine, but it takes a long time to reach harvest and to establish its qualified…
The antitumor activity ofBifidobacterium breve K-110, and K-111, andB. infantis K-525 was investigated. TheseBifidobacterial…
Antidiarrheal, anticostive and antimutagenic effects of Bifidobacterium breve K-110, K-111 and B. infantis K-525 isolated from…
The protective effect of Bifidobacterium breve K-110, K-111 and B. infantis K-525 on carbon tetrachloride induced hepatotoxicity…
저자 등이 건강한 한국사람으로부터 장내유해효소를 억제할 수 있은 장내환경개선효과가 우수한 한국형 유산균을 분리하여 소장수송능 효과, castor oil…